Antihistamines Drugs Pharmacology 2024.ppt

hashirchishti78 87 views 30 slides Aug 04, 2024
Slide 1
Slide 1 of 30
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30

About This Presentation

Pharma drugs which are anihistamines


Slide Content

Antihistamines Antihistamines
Dr. Wardah Siddique
Assistant Prof. Pharmacology

HistamineHistamine
An important mediator of An important mediator of
1. allergic and inflammatory reaction 1. allergic and inflammatory reaction
2. it has an important role in gastric 2. it has an important role in gastric
acid secretion; and functions as a acid secretion; and functions as a
neurotransmitter and neuromodulator neurotransmitter and neuromodulator
3. 3. histamine also plays a role in histamine also plays a role in
chemotaxis of WBCs chemotaxis of WBCs

Histamine exerts its biological actions by Histamine exerts its biological actions by
combining with specific cellular receptors combining with specific cellular receptors
located on the surface membrane. located on the surface membrane.
present in lungs, skin, blood vessels,
and GI tract,
Found at high concentration in mast
cells and basophils, and as
neurotransmitter in brain
Also occurs as a component of venoms
and in secretions from insect stings
HH
11 , H , H
22 , H , H
3 3 , H, H
44

H
1
= Smooth
muscle,
endothelium, brain
H
2 = Gastric Mucosa,
Cardiac muscles, mast
cells
H
3 = Presynaptic: Brain,
myenteric plexus, other
neurons
H
4
Eosinophils,
Neutrophils,
CD4T cells

Synthesis: Histamine is 
formed by the decarboxylation of
histidine by histidine
decarboxylase In mast cells,
histamine is stored in granules
If histamine is not stored, it is
rapidly inactivated by the enzyme
amine oxidase

Upon release!Upon release!
It causes:

CVS:
Vasodilation ( H
1 & H
2)
H
1 Rapid
H
2
Slow – sustained
Increased capillary permeability (H
1) (H
2 uncertain)
Effects on small vessels passage of plasma
proteins and fluid in extracellular space, increased
flow of lymph & its protein content lead to edema
It causes SM contraction

Triple response
Localized red spot (direct effect)
Brighter red flush (Flare) *indirect , histamine
induced stimulation of axon reflexes cause
vasodilation.
Wheal formation (increase capillary
permeability)
Histamine Shock (large doses)
anaphylaxis
Marked fall in BP
diminished effective blood volume, reduced
venous return, decreased COP

Heart: (H
2 more) (H
1 less only on AV node)

Increase force of contraction

Increase heart rate

Positive inotropic and positive chronotropic
Constriction of larger vessels in some
species

Extra vascular smooth muscles

It stimulates more, rarely relaxes various
smooth muscles.
Contraction H
1
Relaxation H
2
Bronchospasm is observed with H
1
receptor
stimulation, especially in asthma or some
other pulmonary diseases. (less pronounced
in normal population)
Although the spasmogenic influence of H
1
receptors is dominant in Human Bronchial
Muscles, H
2
with dilator effect are also present, therefore histamine-induced response in
vitro is potentiated with H
2
blockade

In asthmatic patients histamine induced
response may involve additional reflex
component that arises from irritation of
afferent nerve endings.
Uterus : mild contraction ( in humans this
effect is negligible)

Exocrine Glands:

Histamine is an important physiological regulator of
gastric acid secretion (H
2
)

Nerve endings (pain, itch and indirect effect)

Stimulates various nerve endings

When released in epidermis causes itch

When released in dermis evokes pain with or without
itching

Indirect effect (explained earlier – bronchospasm, flare)

HH
11 Receptor antagonists Receptor antagonists
Classification:
They are classified in two generations.
The basis of this classification is the
sedative property and the ability to block
autonomic receptors.

ClassificationClassification

First Generation

Ethanolamines

Carbinoxamine

Dimenhydrinate
Diphenhydramine

Doxylamine

Ethylaminediamines

Pyrilamine

Tripelennamine

Piperazine derivatives

Hydroxyzine

Cyclizine

Meclizine

Alkylamines

Brompheniramine

Chlorpheniramine

Phenothiazine derivatives
Promethazine

Miscellaneous
cyproheptadine
Second generation

Piperidines
Fexofenadine

Miscellaneous
Loratadine
cetirizine
Desloratadine
Levocetirizine

First generation
drugs
Penetrate the
CNS and cause
sedation
Interact with
other receptors,
producing a
variety of
unwanted
adverse effects
Second-generation
agents
Do not penetrate the
BBB causing less
CNS depression
Desloratadine,
fexofenadine and
loratadine show the
least sedation
Cetirizine and
levocetirizine are
partially sedating

Pharmacological properties of AntihistaminesPharmacological properties of Antihistamines

Smooth muscles:
H
1
blockers --- inhibit most responses of smooth
muscles to histamine

Capillary permeability:
decrease the permeability – formation of edema
and wheal.

Exocrine glands:

Gastric secretions – not inhibited by H
1

Histamine-evoked salivary, lacrimal, and other
exocrine secretions – suppressed with variable
response

Non-histamine receptor mediated action – lessened
secretions in cholinergically innervated glands –
e.g., respiratory tree

Immediate Hypersensitivity Reactions: Anaphylaxis and Immediate Hypersensitivity Reactions: Anaphylaxis and
AllergyAllergy
Histamine is one of many potent autacoids released
(along with others e.g., prostaglandins D
2) -- the
protection afforded by antihistamines thus also varies
accordingly

Some phenomena – edema formation and
itch are effectively suppressed

Hypotension – less effected

Bronchoconstriction: reduced little if at all.

Central Nervous SystemCentral Nervous System
First Generation:

Both stimulate and depress the CNS
Stimulation occasionally after conventional doses–
restlessness, nervousness, unable to sleep.
Central excitation – striking feature of poisoning –
convulsions, particularly in infants.

Central depression
Usual accompaniment of therapeutic doses (esp.
older antihistamines)
Diminished alertness, slowed reaction times, and
somnolence (varied response)

CNSCNS
Second-Generation: (non-sedating)
In therapeutic doses do not cross BBB
appreciably
Can be safely used by many patients for
whom sedation is a problem
Capacity to counter Motion Sickness
Anticholinergic property of some
Antihistamines is responsible
Dimenhydrinate, diphenhydramine, various
piperazine derivatives, promethazine (strongest
antimuscarinic activity)

Anticholinergic effectsAnticholinergic effects
First generation H
1
antagonists – inhibit
acetylcholine response at muscarinic
receptors (atropine-like action)
Second generation – no effect on
muscarinic receptors

Local Anesthetic effectLocal Anesthetic effect
At higher doses some H
1
antagonist have
local anesthetic effect activity
(promethazine)

PharmacokineticsPharmacokinetics
1
st
generation:

Well absorbed from GIT, can be given
parenteral

Distributed widely including CNS (first
generation)

Excreted variably in urine, mostly appear in
metabolites

Eliminated more rapidly by children than by
adults, more slow in those with liver disorders

Induce hepatic microsomal enzyme – may
facilitate their own metabolism

PharmacokineticsPharmacokinetics
Second generation:

Rapidly absorbed from GIT

Metabolized in the liver

Excreted in the urine

Fexofenadine excreted in feces

Adverse effects of AntihistamineAdverse effects of Antihistamine

Sedation:

Highest incidence in 1
st
generation, not a feature of 2
nd

generation

Although it may be a desirable adjunct in treatment of some
patients, interferes with daytime activities

Dizziness

Tinnitus

Lassitude

In-coordination

Fatigue

Blurred vision

Diplopia

Euphoria

Nervousness

Insomnia

tremors

Loss of appetite
Nausea
Vomiting
Epigastric distress
Constipation OR diarrhea
these can be decreased by giving the drug with meals
Some antagonists increase appetite and may cause
weight gain
Gastrointestinal Tract

Side effects caused by anti-muscarinic
Action of H
1 antagonist
Dryness of mouth and respiratory
passage
Cough may be there
Urinary retention or frequency
Dysuria


Drug allergy may develop, more common
after topical application
Drug induced fever
Photosensitization

Hematological complications

Leukopenia

Agranulocytosis

Hemolytic anemia (rare)

Teratogenic effects seen with piperazine
compounds – others not noted

Acute poisoning with HAcute poisoning with H
11 antagonists antagonists
Central excitatory effects constitute the
greatest danger

Hallucinations

Excitement

Ataxia

Incoordination

Athetosis

convulsions

Therapeutic Uses:Therapeutic Uses:
Diseases of allergy

Most useful in acute type of allergies
Rhinitis
Urticaria
Conjunctivitis
Dermatitis medicamentosa
Allergic dermatitis
Motion sickness, vertigo, nausea &
vomiting
Anticholinergic property of some Antihistamines is responsible
In controlling motion sickness

Insomnia
Diphenhydramine ( 25mg / night)
Hydroxizine ( 25mg /night)
Advantage – no dependence, but anticholinergic
activity is unwanted
Limited use in asthma
In systemic anaphylaxis- where other
autacoids are also involved these are
used as adjuvant (mainstay therapy is
epinephrine)

H2 blockers H2 blockers
Cimetidine ◦ Ranitidine ◦ Famotidine ◦
Nizatidine
You will read in detail with peptic ulcer
Thank you